162 related articles for article (PubMed ID: 26605217)
1. Silver nitrate versus tetracycline in pleurodesis for malignant pleural effusions; a prospective randomized trial.
Tabatabaei SA; Hashemi SM; Kamali A
Adv Biomed Res; 2015; 4():178. PubMed ID: 26605217
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety profile of autologous blood versus tetracycline pleurodesis for malignant pleural effusion.
Keeratichananont W; Limthon T; Keeratichananont S
Ther Adv Respir Dis; 2015 Apr; 9(2):42-8. PubMed ID: 25663279
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions.
Paschoalini Mda S; Vargas FS; Marchi E; Pereira JR; Jatene FB; Antonangelo L; Light RW
Chest; 2005 Aug; 128(2):684-9. PubMed ID: 16100154
[TBL] [Abstract][Full Text] [Related]
4. Is silver nitrate an effective means of pleurodesis?
Bucknor A; Harrison-Phipps K; Davies T; Toufektzian L
Interact Cardiovasc Thorac Surg; 2015 Oct; 21(4):521-5. PubMed ID: 26188199
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial.
Keeratichananont W; Kaewdech A; Keeratichananont S
Ther Adv Respir Dis; 2018; 12():1753466618816625. PubMed ID: 30526440
[TBL] [Abstract][Full Text] [Related]
6. Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin.
Martínez-Moragón E; Aparicio J; Rogado MC; Sanchis J; Sanchis F; Gil-Suay V
Eur Respir J; 1997 Oct; 10(10):2380-3. PubMed ID: 9387969
[TBL] [Abstract][Full Text] [Related]
7. Safety and systemic consequences of pleurodesis with three different doses of silver nitrate in patients with malignant pleural effusion.
Terra RM; Bellato RT; Teixeira LR; Chate RC; Pego-Fernandes PM
Respiration; 2015; 89(4):276-83. PubMed ID: 25823909
[TBL] [Abstract][Full Text] [Related]
8. [Tetracycline pleurodesis for treatment of malignant pleural effusions. Retrospective study of 91 cases].
Martínez Moragón E; Aparicio Urtasun J; Sanchis Aldás J; Fullana Monllor J; Sanchis Moret F; Montalar Salcedo J; Marco Martínez V
Med Clin (Barc); 1993 Jul; 101(6):201-4. PubMed ID: 8332018
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of doxycycline versus iodopovidone for pleurodesis through an intercostal tube in malignant pleural effusions: a randomized trial.
Damaraju V; Sehgal IS; Muthu V; Prasad KT; Dhooria S; Aggarwal AN; Agarwal R
Support Care Cancer; 2023 Jul; 31(8):454. PubMed ID: 37428348
[TBL] [Abstract][Full Text] [Related]
10. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
11. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions.
Ong KC; Indumathi V; Raghuram J; Ong YY
Respirology; 2000 Jun; 5(2):99-103. PubMed ID: 10894097
[TBL] [Abstract][Full Text] [Related]
13. Effect of chest tube size on pleurodesis efficacy in malignant pleural effusion: a meta-analysis of randomized controlled trials.
Thethi I; Ramirez S; Shen W; Zhang D; Mohamad M; Kaphle U; Kheir F
J Thorac Dis; 2018 Jan; 10(1):355-362. PubMed ID: 29600067
[TBL] [Abstract][Full Text] [Related]
14. Rapid pleurodesis is an outpatient alternative in patients with malignant pleural effusions: a prospective randomized controlled trial.
Özkul S; Turna A; Demirkaya A; Aksoy B; Kaynak K
J Thorac Dis; 2014 Dec; 6(12):1731-5. PubMed ID: 25589966
[TBL] [Abstract][Full Text] [Related]
15. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
Mohsen TA; Zeid AA; Meshref M; Tawfeek N; Redmond K; Ananiadou OG; Haj-Yahia S
Eur J Cardiothorac Surg; 2011 Aug; 40(2):282-6. PubMed ID: 20961772
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Povidone-iodine Pleurodesis in Malignant Pleural Effusions.
Kahrom H; Aghajanzadeh M; Asgari MR; Kahrom M
Indian J Palliat Care; 2017; 23(1):53-56. PubMed ID: 28216863
[TBL] [Abstract][Full Text] [Related]
17. Pleurodesis with povidone-iodine, as an effective procedure in management of patients with malignant pleural effusion.
Godazandeh G; Qasemi NH; Saghafi M; Mortazian M; Tayebi P
J Thorac Dis; 2013 Apr; 5(2):141-4. PubMed ID: 23585939
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions.
Neto JD; de Oliveira SF; Vianna SP; Terra RM
Respirology; 2010 Jan; 15(1):115-8. PubMed ID: 19947987
[TBL] [Abstract][Full Text] [Related]
19. Comparison between pleurodesis results by 50% glucose solution, versus Bleomycin pleurodesis in patients with malignant pleural effusion.
Talebzadeh H; Nazari Sabet M
Int J Physiol Pathophysiol Pharmacol; 2023; 15(5):134-141. PubMed ID: 38022726
[TBL] [Abstract][Full Text] [Related]
20. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions.
Parulekar W; Di Primio G; Matzinger F; Dennie C; Bociek G
Chest; 2001 Jul; 120(1):19-25. PubMed ID: 11451810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
